Single inhaler triple therapy in patients with COPD: patient-reported dyspnoea and health status from the IMPACT Trial

被引:0
|
作者
Tabberer, Maggie [1 ]
Jones, Christine Elaine [2 ]
Kilbride, Sally [1 ]
Criner, Gerard J. [3 ]
Lange, Peter [4 ]
Han, Meilan K. [5 ]
Martinez, Fernando [6 ]
Lipson, David A. [7 ]
机构
[1] GSK, Uxbridge, Middx, England
[2] GSK, Res Triangle Pk, NC USA
[3] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA
[4] Univ Copenhagen, Copenhagen, Denmark
[5] Univ Michigan, Pulm & Crit Care, Ann Arbor, MI 48109 USA
[6] New York Presbyterian Hosp, Weill Cornell Med Ctr, New York, NY USA
[7] GSK, King Of Prussia, PA USA
关键词
D O I
10.1183/13993003.congress-2018.PA1996
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
PA1996
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Single Inhaler Triple Therapy (ics/lama/laba) In Patients With Advanced COPD: Patient Reported Symptom And Inhaler Preference Results From The Fulfil Trial
    Tabberer, M.
    Lomas, D.
    Barnacle, H.
    Birk, R.
    Brealey, N.
    Zhu, C. -Q.
    Pascoe, S.
    Locantore, N.
    Lipson, D. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [2] Single inhaler triple therapy in patients with COPD: response rates in health-related quality of life in the IMPACT Trial
    Tabberer, Maggie
    Jones, Christine Elaine
    Kilbride, Sally
    Criner, Gerard J.
    Lange, Peter
    Han, Meilan K.
    Martinez, Fernando
    Lipson, David A.
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [3] Single inhaler triple therapy effective in patients with COPD
    Coats, Tim
    Marks, Richard
    Mayor, Susan
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2016, 77 (10) : 558 - 558
  • [4] Is single-inhaler triple therapy for COPD cost-effective in the UK? The IMPACT trial
    Martin, Alan
    Shah, Dhvani
    Ndirangu, Kerigo
    Anley, Glenn A.
    Okorogheye, Gabriel
    Schroeder, Melanie
    Risebrough, Nancy
    Ismaila, Afisi S.
    ERJ OPEN RESEARCH, 2022, 8 (01)
  • [5] Economic evaluation of the impact of exacerbation frequency in COPD patients treated with single-inhaler triple therapy in Spain: The IMPACT trial
    Amanda Vallejo, Laura
    Paly, Victoria
    Martin, Alan
    Risebrough, Nancy
    Abreu, Catarina
    Izquierdo, Jose Luis
    Riesco, Juan Antonio
    Soler-Cataluna, Juan Jose
    Ismaila, Afisi S.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [6] Single-Inhaler Triple versus Dual Therapy in Patients with COPD
    Rolla, Giovanni
    Brussino, Luisa
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (06): : 590 - 591
  • [7] Once-Daily Triple Therapy in Patients with COPD: Patient-Reported Symptoms and Quality of Life
    Tabberer, Maggie
    Lomas, David A.
    Birk, Ruby
    Brealey, Noushin
    Zhu, Chang-Qing
    Pascoe, Steve
    Locantore, Nicholas
    Lipson, David A.
    ADVANCES IN THERAPY, 2018, 35 (01) : 56 - 71
  • [8] Once-Daily Triple Therapy in Patients with COPD: Patient-Reported Symptoms and Quality of Life
    Maggie Tabberer
    David A. Lomas
    Ruby Birk
    Noushin Brealey
    Chang-Qing Zhu
    Steve Pascoe
    Nicholas Locantore
    David A. Lipson
    Advances in Therapy, 2018, 35 : 56 - 71
  • [9] Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study
    Tabberer, Maggie
    Jones, C. Elaine
    Kilbride, Sally
    Halpin, David M. G.
    Lomas, David A.
    Pascoe, Steven
    Singh, Dave
    Wise, Robert A.
    Criner, Gerard J.
    Lange, Peter
    Dransfield, Mark T.
    Han, Meilan K.
    Martinez, Fernando J.
    Kaisermann, Morrys C.
    Lipson, David A.
    ADVANCES IN THERAPY, 2020, 37 (09) : 3775 - 3790
  • [10] Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study
    Maggie Tabberer
    C. Elaine Jones
    Sally Kilbride
    David M. G. Halpin
    David A. Lomas
    Steven Pascoe
    Dave Singh
    Robert A. Wise
    Gerard J. Criner
    Peter Lange
    Mark T. Dransfield
    MeiLan K. Han
    Fernando J. Martinez
    Morrys C. Kaisermann
    David A. Lipson
    Advances in Therapy, 2020, 37 : 3775 - 3790